| 1 |
Restoring the Balance between Pro-Inflammatory and Anti-Inflammatory Cytokines in the Treatment of Rheumatoid Arthritis: New Insights from Animal Models
Adrienn Markovics, Ken S. Rosenthal, Katalin Mikecz et al. · Biomedicines
Open access |
26 Dec 2021 |
58 |
| 2 |
Vaccines: All Things Considered
Ken S. Rosenthal, Daniel H. Zimmerman · Clinical and Vaccine Immunology
Open access |
Aug 2006 |
50 |
| 3 |
Design and Operational Performance of Double Crossover Intersection and Diverging Diamond Interchange
Joe G. Bared, Praveen K. Edara, Ramanujan Jagannathan · Transportation Research Record Journal of the Transportation Research Board
|
2005 |
49 |
| 4 |
Immunization with a LEAPS™ heteroconjugate containing a CTL epitope and a peptide from beta-2-microglobulin elicits a protective and DTH response to herpes simplex virus type 1
Ken S. Rosenthal, Hanwen Mao, Walter I. Horne et al. · Vaccine
|
Feb 1999 |
46 |
| 5 |
CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine/chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse model
Daniel H. Zimmerman, Patricia Taylor, Alison M. Bendele et al. · International Immunopharmacology
|
15 Jan 2010 |
36 |
| 6 |
Rheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritis
Kenneth S. Rosenthal, Katalin Mikecz, Harold L Steiner et al. · Expert Review of Vaccines
Open access |
18 Mar 2015 |
33 |
| 7 |
Flt3 ligand enhances the immunogenicity of a gag-based HIV-1 vaccine
Vladimir M. Pisarev, Prahlad Parajuli, Rodney Lee Mosley et al. · International Journal of Immunopharmacology
|
Nov 2000 |
24 |
| 8 |
An epitope-specific DerG-PG70 LEAPS vaccine modulates T cell responses and suppresses arthritis progression in two related murine models of rheumatoid arthritis
Katalin Mikecz, Tibor T. Glant, Adrienn Markovics et al. · Vaccine
Open access |
4 Jun 2017 |
22 |
| 9 |
The ability of an HSV strain to initiate zosteriform spread correlates with its neuroinvasive disease potential
Neena Goel, Hongyi Mao, Q. Rong et al. · Archives of Virology
|
Apr 2002 |
22 |
| 10 |
CEL-1000—a peptide with adjuvant activity for Th1 immune responses
Yupin Charoenvit, Neena Goel, Michael Whelan et al. · Vaccine
|
9 Apr 2004 |
22 |
| 11 |
The Effect of Leukocyte Interleukin Injection (Multikine®) Treatment on the Peritumoral and Intratumoral Subpopulation of Mononuclear Cells and on Tumor Epithelia: A Possible New Approach to Augmenting Sensitivity to Radiation Therapy and Chemotherapy in Oral Cancer—A Multicenter Phase I/II Clinical Trial
József Tı́már, Csaba Forster‐Horváth, Júlia Lukits et al. · The Laryngoscope
|
Dec 2003 |
21 |
| 12 |
J-LEAPS vaccines initiate murine Th1 responses by activating dendritic cells
Philip R. Taylor, Gary K. Koski, Christopher C. Paustian et al. · Vaccine
|
26 Jun 2010 |
21 |
| 13 |
Maturation of dendritic cell precursors into IL12-producing DCs by J-LEAPS immunogens
Patricia Taylor, Christopher C. Paustian, Gary K. Koski et al. · Cellular Immunology
Open access |
2010 |
17 |
| 14 |
Antigen-activated dendritic cells ameliorate influenza A infections
Kobporn Boonnak, Leatrice Vogel, Marlene S. Orandle et al. · Journal of Clinical Investigation
Open access |
23 Jun 2013 |
17 |
| 15 |
The L.E.A.P.S. approach to vaccine development
Hsu Daniel · Frontiers in bioscience
Open access |
2005 |
17 |
| 16 |
A New Oil-Based Antigen Delivery Formulation for both Oral and Parenteral Vaccination
Marta de Oliveira Domingos, David J. M. Lewis, Theo Jansen et al. · The Open Drug Delivery Journal
Open access |
24 Jul 2008 |
16 |
| 17 |
Flt3 ligand and conjugation to IL-1β peptide as adjuvants for a type 1, T-cell response to an HIV p17 gag vaccine
Vladimir M. Pisarev, Prahlad Parajuli, Rodney Lee Mosley et al. · Vaccine
|
May 2002 |
16 |
| 18 |
J‐LEAPS peptide and LEAPS dendritic cell vaccines
Ken S. Rosenthal, Patricia R. Taylor, Daniel H. Zimmerman · Microbial Biotechnology
Open access |
6 Sep 2011 |
16 |
| 19 |
A Small Peptide (CEL-1000) Derived from the β-Chain of the Human Major Histocompatibility Complex Class II Molecule Induces Complete Protection against Malaria in an Antigen-Independent Manner
Yupin Charoenvit, Gary T. Brice, David Bacon et al. · Antimicrobial Agents and Chemotherapy
Open access |
23 Jun 2004 |
15 |
| 20 |
Induction of cross clade reactive specific antibodies in mice by conjugates of HGP-30 (peptide analog of HIV-1SF2 p17) and peptide segments of human β-2-microglobulin or MHC II β chain
Daniel H. Zimmerman, JOHN P. LLOYD, Daniel A.R. Heisey et al. · Vaccine
|
Sep 2001 |
15 |
| 21 |
L.E.A.P.S. heteroconjugate is able to prevent and treat experimental autoimmune myocarditis by altering trafficking of autoaggressive cells to the heart
Daniela Čiháková, Jobert G. Barin, G. Christian Baldeviano et al. · International Immunopharmacology
Open access |
30 Jan 2008 |
15 |
| 22 |
Vaccination by Two DerG LEAPS Conjugates Incorporating Distinct Proteoglycan (PG, Aggrecan) Epitopes Provides Therapy by Different Immune Mechanisms in a Mouse Model of Rheumatoid Arthritis
Daniel H. Zimmerman, Katalin Mikecz, Adrienn Markovics et al. · Vaccines
Open access |
2 May 2021 |
14 |
| 23 |
A modification of the epidermal scarification model of herpes simplex virus infection to achieve a reproducible and uniform progression of disease
Neena Goel, John J. Docherty, Ming Fu et al. · Journal of Virological Methods
|
21 Oct 2002 |
12 |
| 24 |
Booster immunization of HIV-1 negative volunteers with HGP-30 vaccine induces protection against HIV-1 virus challenge in SCID mice
Prem S. Sarin, James E. Talmadge, Peter N.R. Heseltine et al. · Vaccine
|
1999 |
12 |
| 25 |
LEAPS Therapeutic Vaccines as Antigen Specific Suppressors of Inflammation in Infectious and Autoimmune Diseases
Daniel H. Zimmerman · Journal of Vaccines & Vaccination
Open access |
2012 |
10 |
| 26 |
Two Low-Cost Safety Concepts for Two-Way, Stop-Controlled Intersections in Rural Areas
Frank B. Gross, Ram Jagannathan, Warren Hughes · Transportation Research Record Journal of the Transportation Research Board
|
2009 |
10 |
| 27 |
Why Don't We Have a Vaccine Against Autoimmune Diseases? - A Review.
Ken S. Rosenthal, Roy E. Carambula, Daniel H. Zimmerman · PubMed
Open access |
2019 |
9 |
| 28 |
LEAPS Vaccine Incorporating HER-2/neu Epitope Elicits Protection That Prevents and Limits Tumor Growth and Spread of Breast Cancer in a Mouse Model
Ken S. Rosenthal, Sarah Stone, Gary K. Koski et al. · Journal of Immunology Research
Open access |
2017 |
9 |
| 29 |
Current status of immunological therapies for rheumatoid arthritis with a focus on antigen-specific therapeutic vaccines
Daniel H. Zimmerman, Zoltán Szekanecz, Adrienn Markovics et al. · Frontiers in Immunology
Open access |
6 Mar 2024 |
8 |
| 30 |
Neoadjuvant leukocyte interleukin injection immunotherapy improves overall survival in low-risk locally advanced head and neck squamous cell carcinoma –the IT-MATTERS study
Eyal Talor, József Tı́már, Philip T. Lavin et al. · Pathology & Oncology Research
Open access |
21 Mar 2025 |
5 |
| 31 |
Lessons from next generation influenza vaccines for inflammatory disease therapies
Daniel H. Zimmerman, Roy E. Carambula, Jason C. Ciemielewski et al. · International Immunopharmacology
Open access |
4 Jul 2019 |
5 |
| 32 |
Leukocyte Interleukin, INJ. (LI) Augmentation of Natural Killer Cells and Cytolytic T-Lymphocytes
M. A. Chirigos, Eyal Talor, R. W. Sidwell et al. · Immunopharmacology and Immunotoxicology
|
1995 |
4 |
| 33 |
Road Safety Audits: FHWA Case Study Program
Margaret S. Gibbs, Sany Zein, Dan Nabors et al. · Transportation Research Record Journal of the Transportation Research Board
|
2006 |
4 |
| 34 |
J-LEAPS vaccines elicit antigen specific Th1 responses by promoting maturation of type 1 dendritic cells (DC1)
Ken S. Rosenthal, Daniel H. Zimmerman · AIMS Allergy and Immunology
Open access |
2017 |
3 |
| 35 |
Road Safety Audits
Margaret S. Gibbs, Sany R. Zein, Dan Nabors et al. · Transportation Research Record Journal of the Transportation Research Board
|
2006 |
1 |
| 36 |
A novel neoadjuvant immunotherapy confers improved overall survival in oral cancer patients with low tumor PD-L1 expression The IT-MATTERS Clinical trial – Prognostic role of tumor PD-L1 expression
Eyal Talor, Philip T. Lavin, John Cipriano et al. · Oral Oncology
Open access |
31 Jul 2026 |
0 |
| 37 |
893P Tumor node stage shift following leukocyte interleukin injection neoadjuvant extends overall survival in treatment-naïve locally advanced oral cavity/soft palate squamous cell carcinoma
József Tı́már, Philip T. Lavin, John Cipriano et al. · Annals of Oncology
Open access |
Oct 2023 |
0 |
| 38 |
690P Early response to leukocyte interleukin Injection (LI) immunotherapy extends overall survival (OS) in locally advanced primary squamous cell carcinoma of the head & neck (SCCHN): The IT-MATTERS study
Phillip T. Lavin, Eyal Talor, D. Markovic et al. · Annals of Oncology
Open access |
Sep 2022 |
0 |
| 39 |
Vaccine Immunomodulation of Disease: Targeting the Treatment of Autoimmune Diseases
Ken S. Rosenthal, Daniel H. Zimmerman · Medical Research Archives
Open access |
2022 |
0 |
| 40 |
J-LEAPS Vaccines Mature Mouse Bone Marrow Cells to Dendritic Cells-1 (DC1) which can Deliver Protective Immunity
Patricia Taylor, Gary K. Koski, Erin B. Bailey et al. · Clinical Immunology
|
2010 |
0 |
| 41 |
Su.100. Immunization with a L.E.A.P.S. TM Heteroconjugate Containing the J Peptide from Beta-2 Microglobulin Elicits a T Helper 1 Cytokine Response
Patricia Taylor, Daniel H. Zimmerman, Ken S. Rosenthal · Clinical Immunology
|
2008 |
0 |